Centricity Wealth Management’s ResMed RMD Stock Holding History

Centricity Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$26.3K	Hold	102	–	–	0.02%	229
2025 Q1	$22.8K	Hold	102	–	–	0.02%	238
2024 Q4	$23.3K	Buy	+102	New	+$24.6K	0.02%	236

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Centricity Wealth Management's RMD Position: Q2 2025 in Review

Centricity Wealth Management held its ResMed (RMD) position steady in Q2 2025 at 102 shares worth $26.3K. The position accounts for 0.02% of the portfolio, ranked #229.

Centricity Wealth Management first reported a position in RMD in Q4 2024 and has held it in 3 quarters since. 920 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Centricity Wealth Management held 102 shares of ResMed worth $26.3K as of Q2 2025.
Centricity Wealth Management left its ResMed share count unchanged in Q2 2025.
ResMed made up 0.02% of Centricity Wealth Management's portfolio in Q2 2025, its #229 holding.
Centricity Wealth Management first reported a position in ResMed in Q4 2024 and has held it in 3 quarters since.
920 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Centricity Wealth Management's 13F filing for Q2 2025, filed 18 Jul 2025.